绪 论

1. 李甘地主编. 病理学. 第一版. 北京: 人民卫生出版社, 2001, 1-7

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999,3-11.

第一章、 细胞、组织的适应和损伤

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，8-26

2. Cotran RS, Kumar V, Collins T. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders, 1999, 1- 49

3. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 112-118

第二章、损伤的修复

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社, 2001, 34-56

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 119-126

3. Gabet Y, Muller R, Regev E, Sela J, Shteyer A, Salisbury K, Chorev M, Bab I. Osteogenic growth peptide modulates fracture callus structural and mechanical properties. Bone. 2004 Jul; 35(1): 65-73.

4. Jessen KR. Glial cells. Int J Biochem Cell Biol. 2004 Oct; 36(10):1861-7.

5. Jimenez PA, Jimenez SE. Tissue and cellular approaches to wound repair. Am J Surg. 2004 May;187(5A):56S-64S.

第三章、局部血液循环障碍

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，58-80

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 163-180

3. Gupta SK, Mohanty I, Talwar KK, Dinda A, Joshi S, Bansal P, Saxena A, Arya DS. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem. 2004 May; 260(1-2):39-47

第四章、炎症

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，81-105

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 221-244

3. Baldassarre G, Nicoloso MS, Schiappacassi M, Chimienti E, Belletti B. Linking inflammation to cell cycle progression. Curr Pharm Des. 2004;10(14):1653-66.

4. Danese S, Motte Cd Cde L, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol. 2004 May;99(5):938-45.

5. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004 May;113(9):1318-27.

6. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004 May; 113(9): 1271-6

第五章、肿瘤

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，34-56

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 245-292

3. Crowe DL, Ohannessian A. Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation. BMC Cancer. 2004 May 7;4(1):18.

4. Goncharuk VN, del-Rosario A, Kren L, Anwar S, Sheehan CE, Carlson JA, Ross JS.Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. Ann Diagn Pathol. 2004 Feb;8(1):6-16.

5. Hobbs CG, Birchall MA. Human papillomavirus infection in the etiology of laryngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2004 Apr; 12(2): 88-92.

6. Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate. 2004 Jun 15; 60(1):25-31.

7. Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, Fu P, Mukhtar H. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res. 2004 May 1; 64(9): 3334-43.

8. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene. 2004 Apr 12; 23(16):2919-33.

9. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ. 2004;(157):301-10.

10. Nayak NC. Hepatocellular carcinoma--a model of human cancer: clinico-pathological features, etiology and pathogenesis. Indian J Pathol Microbiol. 2003 Jan; 46(1):1-16.

第六章、心血管系统疾病

1． 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，156-194

2． Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 307-360

3． Asztalos BF. High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study. Curr Opin Cardiol. 2004 Jul; 19(4): 385-91.

4． Correia ML, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens. 2004 Mar;13(2):215-23.

5． Sternberg SS主编，回允中主译. 诊断外科病理学. 第三版. 北京：北京大学出版社，2003，1209-1252

6． 刘彤华主编. 诊断病理学. 北京：人民卫生出版社，1994.834-898.

第七章、呼吸系统疾病

1． 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，196-227

2． Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 361- 400

3． Westmaas JL, Brandon TH. Reducing risk in smokers. Curr Opin Pulm Med. 2004 Jul; 10(4):284-288.

4． Chanin TD, Merrick DT, Franklin WA, Hirsch FR. Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present. Curr Opin Pulm Med. 2004 Jul;10(4):242-247.

5． Muller-Hagen G, Beinert T, Sommer A. Aspects of lung cancer gene expression profiling.: Curr Opin Drug Discov Devel. 2004 May;7(3):290-303.

6． 董郡主编. 病理学. 第二版, 北京：人民卫生出版社，1996.364-427

第八章、消化系统疾病

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，229-267

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 401-484

3. 谭郁彬、张乃鑫主编. 外科诊断病理学. 天津：天津科技出版社，2000.462-474

4. 刘彤华主编. 诊断病理学. 北京：人民卫生出版社，1994.61-64，237-296

第九章、淋巴造血系统疾病

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，269-287

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 657-743

3. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol. 2004 May;125(3):267-81.

4. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004 Mar 25; 350 (13):1328-37.

5. Durosinmi MA, Mabayoje VO, Akinola NO. A review of histology of bone marrow trephine in malignant lymphomas. Niger J Med. 2003 Oct-Dec; 12(4):198-201.

6. Hsi ED, Frater JL. Advances in the diagnosis and classification of chronic lymphoproliferative disorders. Cancer Treat Res. 2004;121:145-65.

7. Izraeli S. Leukaemia - a developmental perspective. Br J Haematol. 2004 Jul;126(1):3-10.

第十章、泌尿系统疾病

1． 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，34-56

2． Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 617-656

3． Julian BA, Novak J. IgA nephropathy: an update. Curr Opin Nephrol Hypertens. 2004 Mar;13(2):171-9.

4． Kohlhagen J, Kelly J. Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure. Nephrology (Carlton). 2003 Dec;8(6):274-9.

5． Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure.: Intern Med. 2004 Jan;43(1):9-17.

6． Quigg RJ. Complement and autoimmune glomerular diseases. Curr Dir Autoimmun. 2004;7:165-80.

7． Ritz E, Adamczak M, Zeier M. Kidney and hypertension-causes. Update 2003. Herz. 2003 Dec;28(8):663-7.

第十一章、生殖系统和乳腺疾病

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，340-373

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 523-616

3. De Palo G. Cervical precancer and cancer, past, present and future. Eur J Gynaecol Oncol. 2004;25(3):269-78.

4. Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol. 2004 Jul;51(1):55-67.

5. Van Diest PJ, Van Der Wall E, Baak JP. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol. 2004 Jul;57(7):675-81.

6. Mazzucchelli R, Barbisan F, Tarquini LM, Galosi AB, Stramazzotti D. Molecular mechanisms in prostate cancer. A review. Anal Quant Cytol Histol. 2004 Jun;26(3):127-33.

7. Tricoli JV, Schoenfeldt M, Conley BA. Detection of prostate cancer and predicting progression: current and future diagnostic markers. : Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3943-53.

第十二章、内分泌系统疾病

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，375-393

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 485-522

3. 刘彤华. 诊断病理学. 北京：人民卫生出版社，1994，324-377

4. 董郡. 病理学. 第二版，北京：人民卫生出版社，1996，749-814

5. 谭郁彬，张乃鑫. 外科诊断病理学. 天津：天津科学技术出版社，2000，537-541，832-893

6. 史景泉，陈意生. 现代外科病理学. 北京：人民军医出版社，1998，233-242，739-793

第十三章、神经系统疾病

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，396-425

2. Underwood JCE. General and Systematic Pathology. 2ed ed. Beijing: Science Press, 1999. 829-886

3. Sternberg SS主编，回允中主译.诊断外科病理学.第三版. 北京：北京大学出版社，2003，389-482

4. 刘彤华主编. 诊断病理学. 北京：人民卫生出版社，1994，899-943.

第十四章、传染病

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，426-469

2. 陈菊梅 主编. 现代传染病学. 北京：人民军医出版社，1999

3. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z, Geng J, Cai J, Han H, Li X, Kang W, Weng D, Liang P, Jiang S. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004 Jun; 203(2): 622-30.

第十五章、寄生虫病

1. 李甘地主编. 病理学. 第一版. 北京：人民卫生出版社，2001，470-488

2. 董郡主编. 病理学. 第二版，北京：人民卫生出版社，1996，1067-1097